                         SEQUENCE LISTING

<110>  CoBioRes NV
 
<120>  Compounds comprising a tetrapeptidic moiety

<130>  CBR-002-2021

<150>  EP21155657 
<151>  2021-02-07

<150>  EP21156381
<151>  2021-02-10

<160>  16    

<170>  PatentIn version 3.5

<210>  1
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X is alanine or valine

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is alanine or valine

<400>  1

Ala Xaa Gly Pro 
1               


<210>  2
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is methionine or asparagine

<400>  2

Xaa Leu Gly Pro 
1               


<210>  3
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is alanine, isoleucine, leucine or valine

<400>  3

Xaa Ala Gly Pro 
1               


<210>  4
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  4

Ala Ala Gly Pro 
1               


<210>  5
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  5

Ala Val Gly Pro 
1               


<210>  6
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  6

Met Leu Gly Pro 
1               


<210>  7
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  7

Asn Leu Gly Pro 
1               


<210>  8
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  8

Ile Ala Gly Pro 
1               


<210>  9
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  9

Leu Ala Gly Pro 
1               


<210>  10
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  10

Val Ala Gly Pro 
1               


<210>  11
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  11

Ala Leu Gly Pro 
1               


<210>  12
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  12

Lys Leu Gly Pro 
1               


<210>  13
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  13

Thr Ser Gly Pro 
1               


<210>  14
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  14

Asp Leu Gly Pro 
1               


<210>  15
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  15

Ala Ile Gly Pro 
1               


<210>  16
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  16

Gly Pro Gly Pro 
1               


